Ambit Biosciences Corp Watch

from 10-Q 36 pages Ambit Biosciences Corporation 2013 Equity Incentive Plan Adopted by the Board of Directors: February 12, 2013 Approved by the Stockholders: May 6, 2013 Ipo Date/Effective Date: May 15, 2013 Amendment and Restated Approved by the Board of Directors: April 4, 2014 Approved by the Stockholders: May 15, 2014

from 8-K 9 pages Ambit Biosciences Corporation Restricted Stock Unit Grant Notice

from 10-Q 8 pages Ambit Biosciences Corporation 2014 Long Term Incentive Program Effective Date: April 4, 2014

from 10-K 1 page Ambit Biosciences Corporation Non-Employee Director Compensation Policy

from 10-K 16 pages Ambit Biosciences Corporation Restated Employment Agreement

from 10-K 16 pages Ambit Biosciences Corporation Restated Employment Agreement

from 10-K 16 pages Ambit Biosciences Corporation Restated Employment Agreement

from S-1/A 2 pages Ambit Biosciences Corporation Non-Employee Director Compensation Policy

from S-1/A 12 pages Ambit Biosciences Corporation 2013 Employee Stock Purchase Plan Adopted by the Board of Directors: February 12, 2013 Approved by the Stockholders: , 2013

from S-1/A 36 pages Ambit Biosciences Corporation 2013 Equity Incentive Plan Adopted by the Board of Directors: February 12, 2013 Approved by the Stockholders: , 2013 Ipo Date/Effective Date: , 2013

from S-1/A 32 pages Ambit Biosciences Corporation Amended and Restated 2011 Equity Incentive Plan Adopted January 24, 2001 Approved by Stockholders February 21, 2001 as Amended by the Board of Directors on June 6, 2001 Amendment Approved by the Stockholders as Amended by the Board of Directors on October 31, 2001 Amendment Approved by the Stockholders as Amended by the Board of Directors on August 12, 2004 Amendment Approved by the Stockholders as Amended by the Board of Directors on March 10, 2005 Amendment Approved by the Stockholders as Amended by the Board of Directors on January 31, 2006 Amendment Approved by the Stockholders as Amended by the Board of Directors on October 24, 2007 Amendment Approved by the Stockholders as Amended by the Board of Directors on November 5 and 6, 2008 Amendment Approved by the Stockholders as Amended by the Board of Directors on August 19, 2010 Amendment Approved by the Stockholders as Amended and Restated by the Board of Directors on January 25, 2011 Amendment and Restatement Approved by the Stockholders as Amended by the Board of Directors on May 18, 2011 Amendment Approved by the Stockholders as Amended by the Board of Directors on May 9, 2011 Amendment Approved by the Stockholders as Amended by the Board of Directors on May 17, 2012 Amendment Approved by the Stockholders as Amended by the Board of Directors on July 17, 2012 as Amended by the Board of Directors on October 26, 2012 Amendment Approved by the Stockholders as Amended by the Board of Directors on December 13, 2012 Amendment Approved by the Stockholders Termination Date: January 24, 2021

from S-1/A 35 pages Collaboration Agreement

from S-1/A 109 pages Exclusive License and Collaborative Research, Co-Development and Commercialization Agreement by and Among Astellas Pharma Inc. and Astellas US LLC and Ambit Biosciences Corporation December 18, 2009 Confidential

from S-1/A 74 pages Collaboration Agreement

from S-1 35 pages Collaboration Agreement

from S-1 109 pages Exclusive License and Collaborative Research, Co-Development and Commercialization Agreement by and Among Astellas Pharma Inc. and Astellas US LLC and Ambit Biosciences Corporation December 18, 2009 Confidential

from S-1 74 pages Collaboration Agreement

from S-1 78 pages Recitals Agreement

from S-1 59 pages 1. Basic Provisions (“Basic Provisions”). 1.1 Parties: This Lease (“Lease”), Dated for Reference Purposes Only July 22, 2004 ,

from S-1 33 pages Security Agreement